Álvarez-Prats, Alejandro <br/><br/>
Combination therapy with an angiotensin II receptor blocker and an HMG-CoA reductase inhibitor in experimental subtotal nephrectomy.  [electronic resource] 

 -  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association  Jul 2012 
 - 2720-33 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2385 
<br/><br/><label>Standard No.: </label>10.1093/ndt/gfr671  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin II Type 1 Receptor Blockers--antagonists & inhibitors<br/>Angiotensin Receptor Antagonists--therapeutic use<br/>Animals<br/>Blotting, Western<br/>Collagen Type I--genetics<br/>Collagen Type III--genetics<br/>Drug Therapy, Combination<br/>Fibronectins--genetics<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Kidney Diseases--etiology<br/>Losartan--therapeutic use<br/>Male<br/>NF-kappa B--genetics<br/>Nephrectomy--adverse effects<br/>Pyridines--therapeutic use<br/>RNA, Messenger--genetics<br/>Rats<br/>Rats, Sprague-Dawley<br/>Real-Time Polymerase Chain Reaction<br/>Reverse Transcriptase Polymerase Chain Reaction